Interleukin-11 for thrombocytopenia associated with hepatitis C

Journal of Clinical Gastroenterology

Volumn 33, Issue 5, 2001, Pages 425-426

  Artz, Andrew S ^a   Ershler, William B ^a   Rustgi, Vinod ^b  

^a Institute for Advanced Studies in Aging and Geriatric Medicine   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; RECOMBINANT INTERLEUKIN 11; RIBAVIRIN;

AGED; CASE REPORT; COMBINATION CHEMOTHERAPY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; FEMALE; HEPATITIS C; HUMAN; LETTER; NONHUMAN; PRIORITY JOURNAL; SEROLOGY; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

AGED; ANTIVIRAL AGENTS; FEMALE; HEPATITIS C; HUMANS; INTERFERON ALFA-2B; INTERLEUKIN-11; RIBAVIRIN; THROMBOCYTOPENIA;

EID: 0034748930     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200111000-00020     Document Type: Letter

References (8)

1. Interferon-induced thrombocytopenia: It is the time for thrombopoietin
2. Is inadequate thrompoietin production a major cause of thrombocytopenia in cirrhosis of the liver?
3. Blunted thrombopoietin response to interferon alfa-induced thrombocytopenia during treatment of hepatitis C
4. Thrombocytopenia associated with hepatitis C viral infection
5. Efficacy of interferon treatment of patients with chronic hepatitis C: Comparison of response in cirrhotics, fibrotics, or nonfibrotics
6. Production of thrombocytopenia (TPO) by rat hepatocytes and hepatoma cell lines
7. Thrombopoietin: The primary regulator of platelet production
8. Interleukin-11 enahances human megakaryocyticopoiesis in vitro